Nov 14, 2023
Lepodisiran - Radical Drug Against Cardiovascular Disease
In #cardiovascular #medicine, #researchers have developed #lepodisiran, a new #drug that shows extraordinary promise in reducing #lipoprotein(a), commonly known as Lp(a), a genetic risk factor for #heartdiseases @neosciencehub #neosciencehub #NSH #heart
In a significant advancement in cardiovascular medicine, researchers have developed Lepodisiran, a new drug that shows extraordinary promise in reducing lipoprotein(a), commonly known as Lp(a), a genetic risk factor for heart disease. Recent human trials have revealed that lepodisiran can lower Lp(a) to undetectable levels, offering hope for a treatment where none currently exists. The Science…
View On WordPress